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Background
The cytochromes P450 (CYP450) 1-3 are involved in 70-
80% of all phase-I dependent metabolism of drugs.
Highly polymorphic CYP450 2D6 gene is coding
biotransformation of about 25% of clinically used medi-
cations, including opioid analgesics, antipsychotics and
antidepressants. Its liver tissue expression is well investi-
gated, but still controversial information is available
regarding the presence in the human brain, as well as the
contribution to psychotropic drug actions and adverse
drug reactions. This review followed-up the published
data according to the localization, regional distribution
and protein expression of CYP 2D6 in CNS and analyzed
the current information about its role in local drug phar-
macokinetics and drug response.
Materials and methods
MEDLINEplus, PubMed, Entrez and Medscape databases
and electronic journals were searched for studies on CYP
2D6 in the human brain. Published research articles and
reviews on pharmacogenetics of oxidative metabolism
and psychotropic drug response were observed for the
potential role of CYP 2D6 brain expression.
Results
Reviewed studies demonstrated CYP2D6 distribution,
CYP2D6 mRNA and protein constitutive expression in
neuronal and glial cells in certain CNS regions [1-3].
Some data supported differences in brain CYP2 induction,
depending on the region, cell type and inducer. CYP2D6
was found to be involved in the brain endogenous sub-
stances metabolism and its enzyme activity could be
under various regulatory mechanisms with potential
influence on drug response [4].
Conclusions
Constitutive expression of CYP2D6 in CNS may create a
local environment of drug metabolism, which, along with
the potential neurotransmitter modulation, may contrib-
ute to altered sensitivity and inter-individual variability in
psychotropic drug response.
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